Scientists test 'Off-the-Shelf' cell therapy for tough blood cancers
Disease control
Ongoing
This is a first-in-human study to find a safe dose of a new, ready-made cell therapy called SENTI-202. It is for adults with advanced blood cancers, like AML or MDS, that have come back or stopped responding to standard treatments. The main goals are to check the safety of the tr…
Phase: PHASE1 • Sponsor: Senti Biosciences • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC